Alembic Limited Company Profile

02:22 EDT 25th June 2018 | BioPortfolio

At Alembic, we recognize that Research and Development is vital for our survival and growth as a leading pharmaceutical firm in India. Research and Development at Alembic is focussed on fermentation technology, strain improvement, industrial enzymes, non-infringing process developments for API & intermediates, development of innovative formulations, NDDS. The Department of Scientific and Industrial Research (DSIR) of the Government of India recognize Alembic's Research and Development Unit since 1975. Research and Development efforts at Alembic are focused on 3 broad categories Chemistry and Synthesis Formulations Development Contract / Collaborated Research


Alembic Road


Phone: +91-265-3007-652
Fax: +91-265-2281-508

News Articles [44 Associated News Articles listed on BioPortfolio]

Alembic receives FDA 483, but no repeat observations nor data issues

Alembic Pharmaceuticals has received a US FDA Form 483 with three observations at a finished formulation plant in Gujarat, India.

Alembic gets FDA nod for Acyclovir ointment

Alembic Pharma's abbreviated new drug application for Acyclovir ointment USP, 5% was approved by the FDA for immunocompromise -More- 

FDA approves Alembic's major depressive disorder tablets

The FDA has approved Indian drugmaker Alembic Pharmaceuticals' abbreviated new drug application for major depressive disorder -More- 

Indian Tax Turbulence Dents Alembic In Q1 - Portends Industry Trend?

Alembic Pharmaceuticals’ first quarter earnings were weighed down by transitional disturbances pertaining to India’s new Goods and Services Tax (GST)...    

FDA approves Alembic’s generic Wellbutrin

Genentech Bets On Kineta's Early-Stage, Disease-Modifying Pain Therapy

Genentech partners with the Seattle biotech on a non-opioid approach to chronic pain. Kineta says there's disease-modifying potential.   

Gilead's Strong HIV Quarter Plus Bictegravir May Portend Sector Dominance

Sales of Gilead's TAF-based regimens for HIV continue to grow and should be augmented by elvitegravir successor bictegravir. The company's...  

Encouraging Survival Data For Lynparza in Metastatic Breast Cancer

OlympiAD data update backs AZ/Merck & Co.'s PARP inhibitor in metastatic breast cancer, but study not powered to give definitive...   

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [83 Associated Companies listed on BioPortfolio]

Alembic Limited

At Alembic, we recognize that Research and Development is vital for our survival and growth as a leading pharmaceutical firm in India. Research and Development at Alembic is focussed on fermentation t...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...



VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Alembic Limited" on BioPortfolio

We have published hundreds of Alembic Limited news stories on BioPortfolio along with dozens of Alembic Limited Clinical Trials and PubMed Articles about Alembic Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alembic Limited Companies in our database. You can also find out about relevant Alembic Limited Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record